| MeSH term | MeSH ID | Detail |
|---|---|---|
| Psoriasis | D011565 | 47 associated lipids |
Total
1
Citraconic acid
Citraconic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 294 references associated with Citraconic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Citraconic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Citraconic acid
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with Citraconic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cao J et al. | Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery. | 2014 | Int J Pharm | pmid:24836667 |
| pmid:24952090 | ||||
| Helwa I et al. | The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes. | 2015 | J. Pharmacol. Exp. Ther. | pmid:25332455 |
| Vego H et al. | Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a. | 2016 | Cell. Mol. Immunol. | pmid:25435072 |
| Xie X et al. | Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway. | 2015 | Br. J. Pharmacol. | pmid:25953698 |
| Gillard GO et al. | DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner. | 2015 | J. Neuroimmunol. | pmid:26004161 |
| Kronen M et al. | Mesaconase Activity of Class I Fumarase Contributes to Mesaconate Utilization by Burkholderia xenovorans. | 2015 | Appl. Environ. Microbiol. | pmid:26070669 |
| pmid:26070834 | ||||
| pmid:26215054 | ||||
| Haarmann A et al. | Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells. | 2015 | Int J Mol Sci | pmid:26287168 |